SCHEMBL9119841

SCHEMBL9119841

Cc1ccc(C2=CC3(C=C2c2ccc(S(N)(=O)=O)nc2)CC3)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.42
PTGS1 P23219 5/20 0.42
CA1 P00915 9/20 0.41
CA2 P00918 9/20 0.41
CA9 Q16790 9/20 0.41
CA5A P35218 6/20 0.41
CA12 O43570 6/20 0.41
CA4 P22748 5/20 0.41
CA6 P23280 3/20 0.41
CA7 P43166 3/20 0.41
CA13 Q8N1Q1 2/20 0.41
CA14 Q9ULX7 2/20 0.41
CA5B Q9Y2D0 4/20 0.34
CA3 P07451 1/20 0.34
HSP90AA1 P07900 1/20 0.33
CXCR5 P32302 1/20 0.33
APLNR P35414 1/20 0.33
RAB9A P51151 1/20 0.33
CCR6 P51684 1/20 0.33
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9117114 0.95 CA1 (0.39) PTGS2PTGS1CA1CA2CA9
SCHEMBL9118877 0.95 CA1 (0.39) PTGS2PTGS1CA1CA2CA9
SCHEMBL9117193 0.88 PTGS2 (0.49) PTGS2PTGS1HSP90AA1CXCR5APLNR
SCHEMBL9116386 0.88 CA1 (0.41) PTGS2PTGS1CA1CA2CA9
SCHEMBL9117806 0.86 PTGS2 (0.55) PTGS2PTGS1CA1CA2CA9
SCHEMBL9115309 0.86 CA1 (0.41) PTGS2PTGS1CA1CA2CA9
SCHEMBL9117037 0.86 PTGS2 (0.42) PTGS2PTGS1CA1CA2CA9
SCHEMBL9118048 0.83 PTGS2 (0.42) PTGS2PTGS1CA1CA2CA9
SCHEMBL9115418 0.83 CA1 (0.42) PTGS2PTGS1CA1CA2CA9
SCHEMBL9118876 0.83 CA1 (0.40) PTGS2PTGS1CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995030652-A1 SUBSTITUTED SPIRODIENES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO claimed
WO-1995030652-A1 SUBSTITUTED SPIRODIENES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed